Kingsley Taft > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices

100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Kingsley Taft

Position
Partner
Career
Kingsley Taft is a senior partner and co-chair of Goodwin’s Life Sciences group and a former member of the Allocations Committee. He represents emerging to mature life sciences companies in all aspects of their business and legal affairs, including company formation, venture financings, strategic alliances, M&A, IPOs and other capital market transactions, and other financing and commercial transactions. Kingsley has extensive experience in assisting clients with JVs, strategic alliances, licenses, and collaborations.
Kingsley has been recognized as a leading life sciences attorney by numerous legal guides. He has been annually ranked for more than 15 years in Chambers USA: America’s Leading Lawyers for Business (Nationwide, Life Sciences: Corporate/Commercial — Band 1). Kingsley was inducted into the LMG Life Sciences Hall of Fame, named a Biotechnology and Life Sciences Lawyer of the Year in 2022 by The Best Lawyers in America and named a Life Sciences Thought Leader by Who’s Who Legal – Global Elite.
Education
JD, 1997, Harvard Law School (magna cum laude) / PhD, Chemistry, 1993, Massachusetts Institute of Technology / BS, Chemistry, 1989, Yale University (magna cum laude)
Lawyer Rankings
United States > Intellectual property > Patents: licensing
Working closely with companies at all stages of growth, in both US and foreign jurisdictions, Goodwin is lauded for its licensing, technology transactions, patent enforcement, prosecution and counseling. Capable of acting in various industries, clients span tech, life sciences, private equity, and financial services. In Boston Catherine McCarty co-heads the IP practice group, bringing expertise in IP to help clients in pharma and chemistry matters protect their innovations. Silicon Valley’s James Riley co-heads the group and frequently represents emerging growth tech companies and venture capital firms in licensing matters. Adept in technology, data and IP transactions is Boston-based lawyer Stephen Charkoudian. Kingsley Taft is well-versed in supporting emerging to mature life science companies. Washington DC’s Noelle Dubiansky possesses broad capabilities in IP including licensing and commercial undertakings for a diverse clientele including biotech, pharma and medical devices. Bethany Withers specializes in tech data, publicity rights and IP matters. Unless otherwise stated, all lawyers are based in Boston.
United States > Healthcare > Life sciences
(Leading partners)Goodwin’s global practice advises biotech, pharma, and healthcare companies, along with life science venture capital and investment firms. The growing practice supports clients in matters as wide-ranging as regulatory compliance, IP and M&A. The team’s representation of Prime Medicine in its $3.5bn deal with Bristol Myers Squibb evidences its excellence in research collaboration and license agreement matters. The practice is headed by Kingsley Taft, vastly experienced in commercial, financing and capital market transactions, and Mitchell Bloom, who specializes in emerging companies and life sciences investors. Both in Boston, transactional lawyer Robert Puopolo and Marishka DeToy, who focuses on capital markets and corporate matters, are key figures in the practice. In DC, Steven Tjoe focuses on product development strategies and FDA regulatory counseling. Arriving on the Boston-based team from Cooley LLP are Joshua Rottner, venture capital and growth equity funds specialist, and Michael McGrail, focused on medical devices and life sciences. Other key hires include litigation expert Michael Siekman, arriving in Boston from McDermott Will & Emery LLP, M&A specialist Amanda Gill, from Paul, Weiss, Rifkind, Wharton & Garrison LLP, and IP lawyer Carl Morales, from Fenwick & West LLP; the latter two are based in New York.
Lawyer Rankings
- Leading partners United States > Healthcare > Life sciences
- Patents: licensing United States > Intellectual property
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation